Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevolution Beauty Regulatory News (REVB)

Share Price Information for Revolution Beauty (REVB)

Share Price is delayed by 15 minutes
Get Live Data
4.65    0.35 (8.14%)
Bid:
4.65
Ask:
4.80
Spread: 0.15 (3.226%)
Market Cap: £40.44m
REVB Live PriceLast checked at - London Stock Exchange

Intraday Revolution Beauty Share Chart

Annual General Meeting

31 Jul 2024 16:59

RNS Number : 6594Y
Revolution Beauty Group PLC
31 July 2024
 

31 July 2024

Revolution Beauty Group plc

("Revolution Beauty", the "Group", or the "Company")

Annual General Meeting

Result of Annual General Meeting

The Annual General Meeting of Revolution Beauty Group plc (Company) was held at 10 Great Pulteney St, London W1F 9NB on 31 July 2024 at 3:00 p.m.

All 12 resolutions put to members were passed on a poll. Resolutions 1 to 10 were passed as ordinary resolutions and resolutions 11 and 12 were passed as special resolutions.

The number of votes cast for and against each of the resolutions proposed, and the number of votes withheld were as follows:

 Resolution

Votes for

%

Votes against

%

Votes withheld

Resolution 1 (Ordinary)

To receive the annual report and accounts for the year ended 29 February 2024.

112,015,796

98.78%

1,379,239

1.22%

15,000

Resolution 2 (Ordinary)

To elect Erin Brookes as a Director.

113,393,022

100.00%

0

0.00%

17,013

Resolution 3 (Ordinary)

To re-elect Chris Fry as a Director.

113,390,352

100.00%

2,670

0.00%

17,013

Resolution 4 (Ordinary)

To re-elect Peter Hallett as a Director.

113,390,752

100.00%

2,270

0.00%

17,013

Resolution 5 (Ordinary)

To re-elect Colin Henry as a Director.

113,390,752

100.00%

2,270

0.00%

17,013

Resolution 6 (Ordinary)

To re-elect Rachel Horsefield as a Director.

113,184,013

99.82%

209,009

0.18%

17,013

Resolution 7 (Ordinary)

To re-elect Alistair McGeorge as a Director.

113,380,358

99.99%

12,664

0.01%

17,013

Resolution 8 (Ordinary)

To appoint MacIntyre Hudson LLP as auditor of the Company.

113,390,752

100.00%

2,270

0.00%

17,013

Resolution 9 (Ordinary)

To authorise the Directors to determine the fees payable to the auditor.

113,392,765

100.00%

2,270

0.00%

15,000

Resolution 10 (Ordinary)

To authorise the Directors to allot equity securities, within the limitations set out in the resolution.

113,387,741

99.98%

22,294

0.02%

0

Resolution 11 (Special)

To disapply pre-emption rights within the limitations set out in the resolution.

113,387,741

99.98%

22,294

0.02%

0

Resolution 12 (Special)

To further disapply pre-emption rights in certain circumstances, within the limitations set out in the resolution.

113,387,741

99.98%

22,294

0.02%

0

 

As at 29 July 2024, there were 318,902,737 ordinary shares in issue. Shareholders are entitled to one vote per share. Votes withheld are not votes in law and so have not been included in the calculation of the proportion of votes for and against a resolution.

The full text of each resolution is available in the Notice of Annual General Meeting, published on the Company's website.

For further information, please contact:

 

Investor Relations

Lauren Brindley, CEO

Neil Catto, CFO

Investor.Relations@revolutionbeautyplc.com

 

Joint Corporate Brokers

Panmure Liberum (NOMAD): Edward Thomas / Dru Danford / John More

Tel: +44 (0) 203 100 2222

 

Zeus: Nick Cowles / Jamie Peel / Jordan Warburton

Tel: +44 (0) 161 831 1512

 

Media enquiries

Headland Consultancy: Matt Denham / Antonia Pollock

Tel: +44 (0)20 3805 4822

Revolutionbeauty@headlandconsultancy.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGQKDBPPBKDOON
Date   Source Headline
5th Jun 20267:00 amRNSFinancial Conduct Authority Update
16th Apr 20267:00 amRNSGrant of Share Options
1st Apr 202611:35 amRNSTotal Voting Rights
11th Mar 20267:00 amRNSAppointment of Nominated Adviser
2nd Mar 202611:28 amRNSTotal Voting Rights
3rd Feb 20264:05 pmRNSTotal Voting Rights
3rd Feb 20264:05 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Jan 20263:48 pmRNSTotal Voting Rights
15th Dec 20256:18 pmRNSDirector/PDMR Shareholding
1st Dec 20255:43 pmRNSTotal Voting Rights
27th Nov 20253:59 pmRNSDirector/PDMR Shareholding
27th Nov 20257:00 amRNSInterim Results
26th Nov 20256:15 pmRNSRelated Party Transaction
4th Nov 20254:32 pmRNSTotal Voting Rights
1st Oct 20257:00 amRNSTotal Voting Rights
30th Sep 20259:33 amRNSResult of AGM
24th Sep 20257:00 amRNSDirectorate Change
18th Sep 20257:00 amRNSHolding(s) in Company
17th Sep 202512:30 pmRNSHolding(s) in Company
17th Sep 20257:00 amRNSDirector/PDMR Shareholding
16th Sep 20255:17 pmRNSHolding(s) in Company
16th Sep 20259:11 amRNSHolding(s) in Company
11th Sep 20254:09 pmRNSResults of General Meeting
2nd Sep 20258:30 amRNSTotal Voting Rights
1st Sep 20255:06 pmRNSHolding(s) in Company
1st Sep 20258:33 amRNSHolding(s) in Company
29th Aug 20254:50 pmRNSFinal Results, Annual Report Posting & AGM Notice
26th Aug 20257:01 amRNSCircular Publication, Notice of GM & Board Update
26th Aug 20257:00 amRNSResult of Retail Offer to existing shareholders
22nd Aug 20254:31 pmRNSPDMR Dealing
22nd Aug 20253:30 pmRNSHolding(s) in Company
22nd Aug 20258:52 amRNSHolding(s) in Company
22nd Aug 20258:40 amRNSRetail Offer to existing shareholders
22nd Aug 20258:09 amRNSResult of Placing and Subscription
22nd Aug 20257:02 amRNSProposed Placing and Subscription via ABB
22nd Aug 20257:01 amRNSPreliminary Unaudited Results
22nd Aug 20257:00 amRNSTermination of Formal Sale Process
21st Aug 202510:51 amRNSForm 8.5 (EPT/RI)
20th Aug 202510:28 amRNSForm 8.5 (EPT/RI)
19th Aug 202512:27 pmRNSFY25 Trading Update
19th Aug 202510:01 amRNSForm 8.5 (EPT/RI)
18th Aug 202510:27 amRNSForm 8.5 (EPT/RI)
15th Aug 20254:11 pmRNSHolding(s) in Company
15th Aug 20259:57 amRNSForm 8.5 (EPT/RI)
14th Aug 202510:25 amRNSForm 8.5 (EPT/RI)
13th Aug 202510:31 amRNSForm 8.5 (EPT/RI)
12th Aug 202510:05 amRNSForm 8.5 (EPT/RI)
11th Aug 202510:26 amRNSForm 8.5 (EPT/RI)
8th Aug 202511:31 amRNSForm 8.5 (EPT/RI)
7th Aug 20254:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.